Showing results (421-430 of 493) with videos related to

Sort By:
Pageof 50
Der Unfallchirurg|June 28, 2008
[Prehospital Trauma Life Support (PHTLS): An interdisciplinary training in preclinical trauma care]C G Wölfl, B Bouillon, C K Lackner, et al.
BMC Cardiovascular Disorders|December 3, 2020
Patients with hip fracture and total hip arthroplasty surgery differ in anthropometric, but not cardiovascular screening abnormalitiesRegina Csanády-Leitner, Franz J Seibert, Corinna M Perchtold-Stefan, et al.
Plos One|July 23, 2019
Creative challenge: Regular exercising moderates the association between task-related heart rate variability changes and individual differences in originalityChristian Rominger, Ilona Papousek, Andreas Fink, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|March 3, 2017
[Cognitive impairments accompanying the burnout syndrome - a review]Karin Riedrich, Elisabeth M Weiss, Nina Dalkner, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 26, 1998
[Direct-current treatment of chemically induced mammary carcinoma in an animal model: MR volumetric assessment of the effect of the therapy]K Krüger, W Heindel, K Fielder, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 4, 1998
[Endorectal MRI and ultrasonography in rectal tumors: correlation with histological staging]W Heindel, A Gossmann, St Ernst, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 1, 1979
[Value and results of computer tomography in diseases of the pancreas (author's transl)]U Mödder, G Friedman, E Bücheler, et al.
Zeitschrift Fur Rheumatologie|March 3, 2004
[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany]P K Schädlich, H Zeidler, A Zink, et al.
Pharmacoeconomics|April 28, 2005
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costsPeter K Schädlich, Henning Zeidler, Angela Zink, et al.
Pharmacoeconomics|April 28, 2005
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiencyPeter K Schädlich, Henning Zeidler, Angela Zink, et al.
Pageof 50